🇺🇸 FDA
Patent

US 9221763

Process for preparing biphenyl imidazole compounds

granted A61PA61P29/00A61P43/00

Quick answer

US patent 9221763 (Process for preparing biphenyl imidazole compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Dec 29 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 24 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P29/00, A61P43/00, A61P9/12